Regulations like the 'Accredited Investor' rule, originally designed to shield small investors from risky ventures, are now perceived as gatekeeping. Retail investors argue these rules don't protect them but instead protect the elite's exclusive access to high-growth, wealth-generating opportunities.

Private credit is being sold to retail investors through products that appear liquid like stocks but are not. These "semi-liquid" funds have clauses allowing them to halt redemptions during market stress, trapping investor capital precisely when they want it most, creating a "run-on-the-bank" panic.

Contrary to the perception that alternatives are complex, their core business models are often simpler than many public market instruments. The concept of direct lending (loaning money and collecting interest) is more straightforward for a retail investor to grasp than the mechanics of a structured note sold by a bank with embedded options.

Sheila Bair argues private credit's dangers lie in investor protection, not systemic risk, due to its lower leverage compared to banks. She points to conflicts of interest, valuation opacity, and liquidity issues as reasons why the asset class is unsuitable for retail investors and 401(k) plans.

Unlike private equity (terminal value) or syndicated loans (interest-only), asset-based finance (ABF) provides front-loaded cash flows of both principal and interest. This structure inherently de-risks the investment over time, often returning significant capital before a potential default occurs.

The SEC plans to overhaul the "accredited investor" definition, which currently limits private market access based on wealth. The goal is to introduce a knowledge-based standard, like a "driver's test," allowing sophisticated but less wealthy individuals (e.g., a finance professor) to participate in private investments.

Well-intentioned regulations like Sarbanes-Oxley increased the burden of going public, causing companies to stay private longer. An unintended consequence is that the bulk of wealth creation now occurs in private markets, accessible only to accredited investors and excluding the general public.

Just as 1700s British aristocrats had lower life expectancies from accessing ineffective but expensive "quack" medicine, today's wealthy investors can access complex financial instruments that often act as financial poison. These products peddle hope but can dramatically increase the odds of ruin, a danger unavailable to ordinary investors.

Sophisticated financial players create and package risky assets, then sell them downstream through pension funds, insurance companies, and now potentially 401(k)s. This 'risk waterfall' ensures that when the underlying assets fail, the losses cascade down to the least informed participants who were told the investments were safe.